Initiation of mRNA decay in Bacillus subtilis

枯草芽孢杆菌中 mRNA 降解的启动

基本信息

项目摘要

DESCRIPTION (provided by applicant): Project Summary: Our laboratory seeks to understand the control of messenger RNA decay in the gram-positive bacterium, Bacillus subtilis. While much is known about the mechanism and regulation of mRNA synthesis (transcription) and translation of mRNA into protein, little is known about the intermediate step in gene expression-degradation of mRNA. Experiments in this proposal focus on 2 aspects of mRNA decay: the elements (e.g., sequences, structures) of an mRNA that determine its half-life, and the ribonuclease activities that are required for initiation and completion of mRNA decay. The availability of B. subtilis strains that are deficient in 1 or more 3'-to-5' exoribonucleases will make it possible to examine the role of individual ribonucleases in mRNA turnover. The decay of 3 small mRNAs, whose characteristics have been studied to some extent, will be analyzed in detail and will serve as models for the study of mRNA decay generally. Experiments are proposed to clarify: 1) what is the initiation site for decay? 2) which ribonuclease(s) participates in initiation of decay? 3) how does the decay mechanism deal with stable secondary structure? and 4) how do the various 3'-to-5' exoribonucleases bind and degrade mRNA? The role of the 4 known B. subtilis 3'-to-5' exoribonucleases -- PNPase, RNase R, RNase PH, and YhaM-will be assessed in the turnover of model mRNAs, as well as newly-identified mRNAs that are stabilized in a PNPase-deficient mutant strain. The likely participation of 2 B. subtilis endoribonucleases -- RNase J1 and RNase J2 -in mRNA decay will be assessed. An in vitro system will be established that will be useful in probing the characteristics of purified ribonucleases, which will be overexpressed and isolated from E. coli. Relevance: Messenger RNA (mRNA) is the template molecule upon which proteins are synthesized. Bacteria rely on rapid mRNA decay to adapt to changing environments, and the details of this process will be studied in detail in the model microorgansim, Bacillus subtilis. Elucidating the mechanism of mRNA in this bacterium could lead to the design of new antibiotics that inhibit the mRNA decay process and thereby prevent successful bacterial colonization of human tissues.
描述(由申请人提供):项目摘要:我们的实验室旨在了解革兰氏阳性细菌枯草芽孢杆菌中信使RNA衰变的控制。虽然对mRNA合成(转录)和mRNA翻译成蛋白质的机制和调控了解很多,但对基因表达的中间步骤-mRNA降解知之甚少。该提案中的实验集中在mRNA衰变的两个方面:元素(例如,序列、结构),其决定mRNA的半衰期,以及mRNA衰变的起始和完成所需的核糖核酸酶活性。B的可用性。缺乏1种或多种3 '至5'核糖核酸外切酶的枯草杆菌菌株将使检查单个核糖核酸酶在mRNA周转中的作用成为可能。3个小mRNA的衰变,其特征已在一定程度上进行了研究,将详细分析,并将作为模型的mRNA衰变的研究一般。提出实验来阐明:1)衰变的起始点是什么?2)哪种核糖核酸酶参与衰变的起始?3)衰变机制如何处理稳定的二级结构?以及4)各种3 '至5'核糖核酸外切酶如何结合和降解mRNA?4已知的B的作用。将在模型mRNA以及在PNPase-deficient突变株中稳定的新鉴定的mRNA的周转中评估枯草杆菌3 '至5'核糖核酸外切酶-PNPaseR、RNasePH和YhaM。2 B的可能参与。将评估枯草杆菌核糖核酸内切酶--RNA酶J1和RNA酶J2 --在mRNA衰变中的作用。将建立一个体外系统,这将是有用的,在探测纯化的核糖核酸酶,这将是过表达和分离从大肠杆菌的特性。杆菌相关性:信使RNA(mRNA)是合成蛋白质的模板分子。细菌依靠快速的mRNA衰变来适应不断变化的环境,这一过程的细节将在模型微生物枯草芽孢杆菌中详细研究。阐明这种细菌中mRNA的机制可能会导致设计新的抗生素,抑制mRNA的衰变过程,从而防止细菌在人体组织中成功定植。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID H BECHHOFER其他文献

DAVID H BECHHOFER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID H BECHHOFER', 18)}}的其他基金

YloC, a new ribonuclease of Bacillus subtilis
YloC,枯草芽孢杆菌的新型核糖核酸酶
  • 批准号:
    10736779
  • 财政年份:
    2023
  • 资助金额:
    $ 32.09万
  • 项目类别:
Global analysis of mRNA decay in Bacillus subtilis
枯草芽孢杆菌 mRNA 衰减的整体分析
  • 批准号:
    8515472
  • 财政年份:
    2012
  • 资助金额:
    $ 32.09万
  • 项目类别:
Global analysis of mRNA decay in Bacillus subtilis
枯草芽孢杆菌 mRNA 衰减的整体分析
  • 批准号:
    8371861
  • 财政年份:
    2012
  • 资助金额:
    $ 32.09万
  • 项目类别:
Global analysis of mRNA decay in Bacillus subtilis
枯草芽孢杆菌 mRNA 衰减的整体分析
  • 批准号:
    8655171
  • 财政年份:
    2012
  • 资助金额:
    $ 32.09万
  • 项目类别:
Initiation of mRNA decay in Bacillus subtilis
枯草芽孢杆菌中 mRNA 降解的启动
  • 批准号:
    7921228
  • 财政年份:
    2009
  • 资助金额:
    $ 32.09万
  • 项目类别:
Initiation of mRNA decay in Bacillus subtilis
枯草芽孢杆菌中 mRNA 降解的启动
  • 批准号:
    6470300
  • 财政年份:
    1993
  • 资助金额:
    $ 32.09万
  • 项目类别:
Initiation of mRNA decay in Bacillus subtilis
枯草芽孢杆菌中 mRNA 降解的启动
  • 批准号:
    7092749
  • 财政年份:
    1993
  • 资助金额:
    $ 32.09万
  • 项目类别:
INITIATION OF MRNA DECAY IN BACILLUS SUBTILIS
枯草芽孢杆菌中 mRNA 衰变的启动
  • 批准号:
    2186314
  • 财政年份:
    1993
  • 资助金额:
    $ 32.09万
  • 项目类别:
INITIATION OF MRNA DECAY IN BACILLUS SUBTILIS
枯草芽孢杆菌中 mRNA 衰变的启动
  • 批准号:
    2022688
  • 财政年份:
    1993
  • 资助金额:
    $ 32.09万
  • 项目类别:
Initiation of mRNA decay in Bacillus subtilis
枯草芽孢杆菌中 mRNA 降解的启动
  • 批准号:
    8073263
  • 财政年份:
    1993
  • 资助金额:
    $ 32.09万
  • 项目类别:

相似海外基金

Mechanistic insights into multifaceted roles of coronavirus exoribonuclease complex
冠状病毒外核糖核酸酶复合物多方面作用的机制见解
  • 批准号:
    10713523
  • 财政年份:
    2023
  • 资助金额:
    $ 32.09万
  • 项目类别:
Novel Function(s) of Arenavirus NP Exoribonuclease
Arenavirus NP 核糖核酸外切酶的新功能
  • 批准号:
    10525101
  • 财政年份:
    2022
  • 资助金额:
    $ 32.09万
  • 项目类别:
Novel Function(s) of Arenavirus NP Exoribonuclease
Arenavirus NP 核糖核酸外切酶的新功能
  • 批准号:
    10624457
  • 财政年份:
    2022
  • 资助金额:
    $ 32.09万
  • 项目类别:
Characterizing the XRN1 exoribonuclease as a therapeutic target in non-small cell lung cancer
将 XRN1 核糖核酸外切酶表征为非小细胞肺癌的治疗靶点
  • 批准号:
    10215766
  • 财政年份:
    2021
  • 资助金额:
    $ 32.09万
  • 项目类别:
Exploring the Coronavirus Exoribonuclease as an Antiviral Target
探索冠状病毒外核糖核酸酶作为抗病毒靶点
  • 批准号:
    10238324
  • 财政年份:
    2021
  • 资助金额:
    $ 32.09万
  • 项目类别:
Characterizing the XRN1 exoribonuclease as a therapeutic target in non-small cell lung cancer
将 XRN1 核糖核酸外切酶表征为非小细胞肺癌的治疗靶点
  • 批准号:
    10656174
  • 财政年份:
    2021
  • 资助金额:
    $ 32.09万
  • 项目类别:
Characterizing the XRN1 exoribonuclease as a therapeutic target in non-small cell lung cancer
将 XRN1 核糖核酸外切酶表征为非小细胞肺癌的治疗靶点
  • 批准号:
    10370384
  • 财政年份:
    2021
  • 资助金额:
    $ 32.09万
  • 项目类别:
Exploiting the SARS-CoV-2 nsp14 3'-5'-exoribonuclease as a target for antiviral chemotherapy
利用 SARS-CoV-2 nsp14 3-5-核糖核酸外切酶作为抗病毒化疗的靶点
  • 批准号:
    MR/V036904/1
  • 财政年份:
    2020
  • 资助金额:
    $ 32.09万
  • 项目类别:
    Research Grant
Dissecting the role of the coronavirus proofreading exoribonuclease in RNA recombination
剖析冠状病毒校对核糖核酸酶在 RNA 重组中的作用
  • 批准号:
    10268982
  • 财政年份:
    2020
  • 资助金额:
    $ 32.09万
  • 项目类别:
Flow responsive endothelial Pnpt1: an exoribonuclease that regulates mitochondrial function and vascular disease
流量响应内皮 Pnpt1:一种调节线粒体功能和血管疾病的核糖核酸外切酶
  • 批准号:
    9750410
  • 财政年份:
    2018
  • 资助金额:
    $ 32.09万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了